 |
1970-73 ,Bachelor equiv.) in Biology from
Anhui Normal University, 1973-78, Lecturer in Medical
Microbiology, Benpu Medical College
1978-1980, for Master in Academia Sinica, 1980-1985,
Ph.D in Beatson Institute for Cancer Research, UK,
1985-1990, P.I, Associated Professor, Shanghai Inst of Cell Biology, Academia Sinica,
1990-June,2001, Senior scientist, P.I, in three academic and one Biotech firm in UK. |
Since June, 2001
P.I of the Cancer Epigenetics and Gene Therapy group,
The State-key Laboratory for Oncogenes and Related Genes,
Shanghai Cancer Institute, Shanghai Jiaotong University, LN2200/25,
Xietu Road, Shanghai 200032, China
Email:zhujingde@sh163.net, @yahoo.com, Tel/Fax: 86-21 64224285
Specialty and Research Field of Interest:
1.Cancer Epigenetics.2. Gene Therapy
The Academic position:
The member of The AACR Epigenome Task Force Committee, USA (29 members in total)
The member of The Asian Epigenome Network (4 members in total)
The member of the grant review panel of UICC;
The member of the grant review panel of Research Grants Council (RGC) of Hong Kong
The member of the standing committee of the biotherapy in Chinese Association of Cancer Research;
The editor of Cell Research, Tumor and five other biomedical journals in China；
The member of Society of Industry Leader USA (http://www.societyofindustryleaders.com), Vista Research, a Division of Standard & Poors, 55 Water Street, 49th Floor, New York, NY 10041, USA
The member of The Network of Healthcare Advisors(www.networkofadvisors.com), 444 Madison Avenue 26th Floor, New York , NY 10022,USA
Recent Publications(since 2005):
[1-10]
1.Zhu, J. and X. Yao, Use of DNA methylation for cancer detection and molecular classification. J Biochem Mol Biol, 2007. 40(2): p. 135-41.
2.Zhang, A.P., et al., The DNA methylation profile within the 5'-regulatory region of DRD2 in discordant sib pairs with schizophrenia. Schizophr Res, 2007. 90(1-3): p. 97-103.
3.Yu, J., et al., and J. Zhu, A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer Clinical Cancer Research, 2007: 13(24):7296-304
4.Huang, J., et al., Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Carcinogenesis, 2007. 28(5): p. 1094-103.
5.Fei, Q., et al, and J. Zhu, Gene therapy for hepatocellular carcinoma by adenoviral-ribozyme mediated inhibition of survivin expression. Cancer Research 2007: p. submitted.
6.Zhu, J.D., et al., Transcription of the putative tumor suppressor gene HCCS1 requires binding of ETS-2 to its consensus near the transcription start site. Cell Res, 2006. 16(9): p. 780-796.
7. Zhu, J., DNA methylation and hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 2006. 13(4): p. 265-73.
8. Zhu, J., The altered DNA methylation pattern and its implications in liver cancer. Cell Res, 2005. 15(4): p. 272-80.
9. Jiang, W., et al., Enhanced efficiency and specificity of ovarian cancer gene therapy in rats with a novel nonviral gene delivery system (GE7) via intraovarian artery perfusion approach. Cancer Gene Ther, 2005. 12(10): p. 810-7.
10.Fu, C., et al., Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene, 2005. 24(35): p. 5401-13.
Research Support:
International Funding: European 6th Frame Program
National Funding: 863, 973 and NSFC
Local Government’s Funding: Shanghai Municipal Government, and Philips Foundation
|
